Human papillomavirus update with a particular focus on cervical disease

Pathology

Volumn 34, Issue 3, 2002, Pages 213-224

  Garland, Suzanne M ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Cervical cancer; Cervical dysplasia; Genital warts; Human papillomavirus; Oncogenesis

Indexed keywords

ANTIRETROVIRUS AGENT; DICHLOROACETIC ACID; PODOPHYLLOTOXIN; VIRUS VACCINE;

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CELL DIFFERENTIATION; CLINICAL FEATURE; CONDYLOMA; CRYOTHERAPY; DEVELOPING COUNTRY; DIATHERMY; DISEASE COURSE; GENOTYPE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR BIOLOGY; NONHUMAN; PATIENT EDUCATION; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS EPITHELIUM; TUMOR CLASSIFICATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VACCINE PRODUCTION; VIRUS INFECTION; VIRUS PATHOGENESIS; WART VIRUS; ANIMAL; CLASSIFICATION; FEMALE; GENETICS; PAPILLOMA VIRUS; PATHOGENICITY; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

ANIMALS; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0035985921     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020212469     Document Type: Article

References (68)

1. A multinational case-control study on the risk of cervical cancer linked to 25 HPV types: Which are the high-risk types?
2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
3. Control of cancer of the cervix uteri: Review article based on a report of a WHO meeting, November 1985, Geneva
4. Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes
5. Biology of genital human papillomaviruses
6. Taxonomic classification of papillomaviruses
7. Partial characterisation of viral DNA from human genital warts
8. Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice
9. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures
10. Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix
11. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy
12. Cervical cancer - What role for human papillomavirus?
13. Progressive genetic aberrations detected by comparative genomic hybridization in clinical stage 1B squamous cell cancer
14. Association of human papillomavirus types 16 and 18 E6 proteins with p53
15. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
16. Juvenile laryngeal papillomatosis in a paediatric population: A clinicopathologic study
17. Human papillomavirus infection and its relationship to recent and distant sexual partners
18. Epidemiology of genital human papillomavirus infection
19. Natural history of cervicovaginal papillomavirus infection in young women
20. Natural history of cervical human papillomavirus in young women: A longitudinal cohort study
21. Immunological events in regressing genital warts
22. Persistence of human papillomavirus 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigen
23. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women
24. The diagnostic value of vaginal smears in carcinoma of uterus
25. Reassessment of the morphological continuum of cervical intraepithelial lesions: Does it reflect different stages in the progression to cervical carinoma?
26. The revised Bethesda system for reporting cervical/vaginal cytological diagnoses: Report of the 1991 Bethesda Workshop
27. Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results
28. Bethesda system
29. The natural history of cervical HPV infection and neoplasia in a large population-based prospective study: The Manchester Cohort
30. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies
31. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses
32. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR
33. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses
34. Improved amplification of genital human papillomavirus
35. New method for the detection and genotyping of human papillomavirus: HPV DNA chip
36. Progression and regression of cervical lesions. Review of smears from women followed without initial biopsy or treatment
37. Behaviour of mid-cervical dysplasia during long-term follow-up
38. Natural history of dysplasia of the uterine cervix
39. HPV international prevalence surveys in general populations
40. Prevalence and determinants of human papillomavirus genital infection in men
41. The risk of cervical cancer in relation to hormonal contraceptives in women that are HPV-DNA carriers. Pooled analysis of the IARC multicentric case-control study
42. HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica
43. Oral contraceptives and cancer: An update
44. Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines
45. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines
46. Human papillomavirus infections in women with HIV disease: Prevalence, risk, and management
47. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription
48. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women
49. Strategies for global control of cervical cancer
50. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
51. HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica
52. Human papillomavirus testing in primary screening of high-grade cervical lesions: A study of 7932 women
53. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial
54. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer
55. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes
56. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri
57. A systematic review of the role of human papillomavirus testing within a cervical screening programme
58. PCR based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears
59. Two-stage cervical cancer screening: An alternative for resource-poor settings
60. Visual inspection with acetic acid for cervical-cancer screen: Test qualities in a primary-care setting
61. Detection of cervical intraepithelial neoplasia in developing countries
62. Genital warts and HPV infection: Diagnosis and management
63. Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts - Results of an open-label, multicentre Phase IIIB trial
64. Mechanism of action of imiquimod